🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Marco Matucci‐Cerinic

Vita-Salute San Raffaele University

ORCID: 0000-0002-9324-3161

Also affiliated with Istituti di Ricovero e Cura a Carattere Scientifico, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.627Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Systematic Analysis of the Literature in Search of Defining Systemic Sclerosis Subsets

The Journal of Rheumatology(2021)10.3899/jrheum.201594
Top 32%
0.627DataRank
Top 32%15 citations

Janet Pope, Matthew Turk, Jenny Shu, April Marquardt, F.H.J. van den Hoogen +7 more

Papers

Driven by 11 papers — median percentile 68. Top paper: “Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial”.

Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial

The Lancet Rheumatology(2020)10.1016/s2665-9913(20)30237-x
N/A
1.1DataRank · unranked
48 citations

Cathie Spino, Richard McLain, Sindhu R. Johnson, Christopher P. Denton, Jerry A. Molitor +27 more

Current and Future Outlook on Disease Modification and Defining Low Disease Activity in Systemic Sclerosis

Arthritis & Rheumatology(2020)10.1002/art.41246
N/A
1.1DataRank · unranked
38 citations

Marco Matucci‐Cerinic, Daniel E. Furst, Masataka Kuwana, Yannick Allanore, Christopher P. Denton +8 more

Mortality in systemic sclerosis: An international meta-analysis of individual patient data

The American Journal of Medicine(2005)10.1016/j.amjmed.2004.04.031
N/A
0.912DataRank · unranked
437 citations

Panayiotis G. Vlachoyiannopoulos, Thomas A. Medsger, Mary Lucas, Clement J. Michet, Masataka Kuwana +14 more

Systematic Analysis of the Literature in Search of Defining Systemic Sclerosis Subsets

The Journal of Rheumatology(2021)10.3899/jrheum.201594
Top 32%
0.627DataRank
Top 32%15 citations

Janet Pope, Matthew Turk, Jenny Shu, April Marquardt, F.H.J. van den Hoogen +7 more

A 24‐Week, Phase IIa, Randomized, Double‐Blind, Placebo‐Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis

Arthritis & Rheumatology(2023)10.1002/art.42477
N/A
0DataRank · unranked
33 citations

Christopher P. Denton, Daniel E. Furst, Maureen D. Mayes, Marco Matucci‐Cerinic, Vanessa Smith +13 more

Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study

Seminars in Arthritis and Rheumatism(2023)10.1016/j.semarthrit.2023.152174
N/A
0DataRank · unranked
27 citations

Corrado Campochiaro, Nicola Farina, Letizia Mariotti, Elena Baldissera, Peter C. Grayson +3 more

Application of logistic regression and machine learning methods for idiopathic inflammatory myopathies malignancy prediction

Clinical and Experimental Rheumatology(2023)10.55563/clinexprheumatol/8ievtq
N/A
0DataRank · unranked
11 citations

Guohai Huang, Kedi Zheng, Jianqun Lin, Shijian Hu, Shaoyu Zheng +7 more

Cellular Players in Gastrointestinal Involvement of Systemic Sclerosis: Insights into Pathogenesis

Cells(2025)10.3390/cells14231930
N/A
0DataRank · unranked
1 citations

Francesco Bonomi, Giulia Bandini, Cristiano Barbetta, Michael Hughes, Francesco Del Galdo +4 more

The race against time to disclose lung inflammation in interstitial lung disease in systemic sclerosis: is PET scan the winning solution?

Lara D. Veeken(2020)10.1093/rheumatology/keaa077
N/A
0DataRank · unranked
0 citations

Marco Matucci‐Cerinic, Silvia Bellando-Randone

OP0171 PHASE 3 TRIAL OF LENABASUM, A CB2 AGONIST, FOR THE TREATMENT OF DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS (DCSSC)

Annals of the Rheumatic Diseases(2021)10.1136/annrheumdis-2021-eular.1795
N/A
0DataRank · unranked
11 citations

Masataka Kuwana, Dinesh Khanna, Laura K. Hummers, Tracy Frech, Wendy Stevens +13 more

Consensus on the assessment of systemic sclerosis–associated primary heart involvement: World Scleroderma Foundation/Heart Failure Association guidance on screening, diagnosis, and follow-up assessment

Journal of Scleroderma and Related Disorders(2023)10.1177/23971983231163413
N/A
0DataRank · unranked
56 citations

Maya H Buch, Aleksandra Djoković, Giacomo De Luca, Raluca B Dumitru, Alessandro Giollo +30 more